Johnson & Johnson's Drug Acquired Via Momenta Deal Shows Encouraging Data In Fetal Disorder
- ByBenzinga-
Janssen, a unit of Johnson & Johnson (NYSE: JNJ), announced topline results from the proof-of-concept Phase 2 open-label UNITY trial for pregnant adults at high risk for severe...